🔗 Share this article

Chancellor Rachel Reeves has revealed she is planning "specific measures to tackle household expense challenges" in the upcoming Budget.

In comments to media outlets, she emphasized that curbing price rises is a shared task of both the government and the central bank.

The United Kingdom's inflation rate is projected to be the highest among the G7 industrialized countries this year and next.

Potential Utility Cost Measures

Reports indicate the government could take action to bring down energy bills, for example by cutting the current 5% level of VAT charged on energy supplies.

Another approach is to reduce some of the regulatory levies presently included in bills.

Budgetary Limitations and Expert Expectations

The administration will obtain the latest draft from the independent fiscal watchdog, the OBR, on the start of the week, which will reveal how much space there is for these actions.

The expectation from most experts is that Reeves will have to introduce tax increases or spending cuts in order to fulfill her self-imposed debt limits.

Earlier on the same day, analysis indicated there was a £22 billion gap for the chancellor to address, which is at the more modest range of expectations.

"There's a shared responsibility between the central bank and the government to continue tackling some of the sources of price increases," the Chancellor told reporters in Washington, at the conferences of the IMF and global financial institution.

Revenue Commitments and Global Concerns

While much of the focus has been on expected tax rises, the chancellor said the latest information from the fiscal watchdog had not changed her commitment to election pledges not to increase rates on income tax, VAT or National Insurance.

She attributed an "unpredictable global environment" with rising geopolitical and trade issues for the Budget tax moves, likely to be targeted on those "most able to pay."

International Trade Tensions

Addressing concerns about the United Kingdom's trade ties with China she said: "Our national security invariably come first."

Last week's declaration by China to increase export controls on critical minerals and other materials that are essential for high-technology manufacturing led American leader the US President to threaten an further 100% tariff on imports from China, increasing the possibility of an all-out trade war between the two largest economies.

The American finance chief called the Chinese action "commercial pressure" and "a global supply chain control attempt."

Inquired about considering the US offer to join its dispute with China, the Chancellor said she was "deeply worried" by China's measures and called on the Beijing authorities "to avoid restrictions and restrict access."

She said the action was "damaging for the world economy and generates further obstacles."

"In my view there are sectors where we must confront Chinese policies, but there are also significant chances to sell into Chinese markets, including banking sector and other sectors of the economic system. We've got to achieve that equilibrium appropriate."

The Treasury chief also confirmed she was cooperating with G7 counterparts "on our own essential resources strategy, so that we are more independent."

NHS Medicine Pricing and Investment

The Chancellor also recognized that the price the NHS pays for drugs could go up as a consequence of current negotiations with the Trump administration and its drugs companies, in exchange for lower tariffs and investment.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either pausing or scrapping projects in the United Kingdom, with several attributing the modest returns they are receiving.

Recently, the Science Minister said the cost the NHS pays for drugs would have to go up to prevent companies and pharmaceutical investment departing from the United Kingdom.

The Chancellor told the BBC: "It has been observed because of the cost structure, that medical research, new drugs have not been available in the UK in the way that they are in other continental states."

"We want to make sure that patients getting treatment from the NHS are can access the top critical treatments in the world. And so we are looking at this situation, and... seeking to secure additional investment into Britain."